Technical Data
A2297-38M
Antibiotic TPU-0037-A (30-Demethyl-lydicamycin)
500ug
|
Technical Data |
|
A2297-38M |
Antibiotic TPU-0037-A (30-Demethyl-lydicamycin) |
500ug |
| Biochemicals | Storage: -20°CShipping: Blue Ice |
|
TPU-0037A, a close structural analogue of lydicamycin, has been shown to be highly active against MRSA. TPU-0037A is also closely related to Antibiotic BN 4515N isolated from a strain of Microtetraspora as a neuritogenic agent. Solubility: Soluble in ethanol, methanol, DMF or DMSO. Storage and Stability: May be stored at -20°C. Reconstitute to nominal volume. Aliquot and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer CAS Number: 485815-59-6 Molecular Formula: C46H72N4O10 Molecular Weight: 841 |
Source: Streptomyces sp. Purity: ~95% by HPLC. Form: Supplied as a colorless film. Specificity: Shown to be highly reactive against MRSA Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. Furumai T. et al. J. Antibiot. 2002, 55, 873. 2. A new neuritogenetic compound BU-4514N produced by Microtetraspora sp.. Toda S. et al. J. Antibiot. 1993, 46, 875. 3. Lydicamycin, a new antibiotic of a novel skeletal type. II. Physico-chemical properties and structure elucidation. Hayakawa Y. et al. J. Antibiot. 1991, 44, 288. 4. Lydicamycin, a new antibiotic of a novel skeletal type. I. Taxonomy, fermentation, isolation and biological activity. Hayakawa Y. et al. J. Antibiot. 1991, 44, 282.
|
||